Journal of Medical Biochemistry (Jan 2022)

Alkaline phosphatase interference in immuno-enzymatic assays

  • Oğuz Osman,
  • Serin Huriye,
  • Hocaoglu Fatma Sinem

DOI
https://doi.org/10.5937/jomb0-33981
Journal volume & issue
Vol. 41, no. 3
pp. 335 – 340

Abstract

Read online

Background: Alkaline phosphatase (ALP) enzymes are widely used as signal amplifiers in immunoenzymatic methods. Conditions that cause ALP elevations, such as bone or liver diseases, can cause interference in immunoenzymatic methods. We aimed to examine ALP's effect on immunoenzymatic assay by adding isolated pure ALP to the prepared serum pool. Methods: We prepared a serum pool and divided it into 4 groups. By adding isolated pure ALP at different concentrations to each group, we obtained sample groups containing ALP enzyme at concentrations of 85 U/L, 340 U/L, 870 U/L, and 1570 U/L. 20-repetition of bhCG, ferritin, FT4, TSH, troponin I, and Vit B12 tests were performed in each group. The coefficient of variation, bias, and total error was calculated. All groups were compared by using the Friedman test for paired samples. Results: After ALP addition, the calculated total error values of FT4, bhCG and troponin I tests were above the acceptable error limits. There were statistically significant differences in bhCG, FT4, troponin I, and Vit B12 tests compared to the baseline ALP level (P<0.0125). Conclusions: Isolated ALP elevations can be a source of interference for immunoenzymatic methods.

Keywords